Summary
For Year 2026-27, Lotus Eye Hospital And Institute reports the following shareholding: Total Promoters at 40.14%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 59.86%. This breakdown provides a quick snapshot of ownership distribution for Lotus Eye Hospital And Institute in 2026-27.
Lotus Eye Hospital And Institute FAQs
As of 04-2026, the promoter shareholding in Lotus Eye Hospital And Institute stands at 40.14% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Lotus Eye Hospital And Institute is 0% and 0% respectively.
The retail shareholding of the Lotus Eye Hospital And Institute is 59.86%.
Changes in shareholding patterns of Lotus Eye Hospital And Institute can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Lotus Eye Hospital And Institute are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Lotus Eye Hospital And Institute Associated Pages
- Lotus Eye Hospital And Institute Share Price
- Lotus Eye Hospital And Institute Share Price chart
- Lotus Eye Hospital And Institute Fundamental Analysis
- Lotus Eye Hospital And Institute Technical Analysis
- Lotus Eye Hospital And Institute Peer Comparison
- Lotus Eye Hospital And Institute Share Price History
- Lotus Eye Hospital And Institute Board of Directors
